An all inclusive ten (10) panel immunoassay* for the simultaneous, specimen collection and screening for multiple drugs of abuse and their metabolites in human urine using one self-contained testing and sample collection device. This safe, accurate and economical testing system is used to obtain a rapid, visual, qualitative result indicating drug usage or abuse within a few minutes. This product will not test for quantitative measurements of drug concentrations in the body but will indicate their presence at or above minimum concentrations established by the NIDA and the World Health Organization.
RapidCheck Pro 10 DSC
incorporates a built-in lateral flow,
multi-panel, chromo-graphic immunoassay for the detection
and identification of
amphetamines, benzoylecgonine (cocaine metabolite), methamphetamines,
opiates and opium derivatives (morphine/heroin/codeine)
tetrahydrocannibinol-9-carboxylic acid (THC, marijuana),
PCP, Methadone, Barbiturates, Benzodiazepines and Methylenedioxymethamphetamine (MDMA)
Ecstasy, in human urine at the
standard minimum cut-off concentration levels based on
the following federal (NIDA) and world (WHO) guidelines
The RapidCheck Pro 10 DSC combination specimen cup and multi-panel drug screen maximizes the simplicity and economics of drug testing programs. Testing is accomplished by simply obtaining a sample specimen. Thereafter the process is completely automatic. Results are read directly from the specimen container itself. The DSC container also has a built-in temperature strip for confirming sample body temperature. This provides an added security check for possible sample substitution or dilution with tap water. The DSC test container also provides an affixed identification label for recording test documentation of date, time, test subject ID etc. Additionally, the container can be sealed for refrigerated storage or transport. Exposure to biological hazards is eliminated as there is no sample handling or device transfer required in the the testing process. This convenient, portable one-step ten panel testing device can be administered any time, at any place, and provide a 98+% accurate and definitive "yes or no" result in about five minutes without the costly and time consuming process of clinical analysis.
After specimen collection, the test is activated using the special key provided. The RapidCheck Pro 10 DSC container immediately begins to develop test results. Lateral flow of the sample across the test panels will begin and depending on the specific target drug panel, control lines and negative test lines may be observed developing in the test panels within thirty to sixty seconds. Any line, no matter how faint, appearing under the control line in the target drug test panel is a negative test for that target drug or drug metabolite. The graphic to the right shows a typical completed development of a single drug test screen. In this case the test is positive for THC and Opiates. Drugs and drug metabolites remain at detectable levels in the human body for various periods of time after use depending on a number of different factors. For a brief discussion and chart regarding the half-life and detectable periods for drugs of abuse see the Drug FAQ.
AVAILABILITY AND ORDERING
The RapidCheck Pro 10 DSC is available in packs of 1, 3, 6, 12, 25, 50 and 100 test packs. For quantities exceeding 100 units please contact us for special volume pricing. Complete use and background information including laboratory testing results, cross reaction charts, drug characteristics and other useful information is included with each test kit. The RapidCheck Pro 10 DSC is 98+% accurate when used in strict accordance to procedural instructions.
For bulk quantity pricing of one hundred (250) units or more please contact us at Customer Service
*This immunoassay provides a preliminary, first-line analytical test result. A more specific alternative chemical method can be used in order to obtain a confirmed laboratory analytical result. Gas chromatography/mass spectrometry (GCIMS) has been established as the preferred confirmatory method by the National Institute on Drug Abuse (NIDA). For specific situations where laboratory confirmation of positive results is required, please refer to the QuickScreen Pro Drug At Home Test page. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.